Real-world Utility and Usability of the Multiple Sclerosis Disease Activity (MSDA) Blood Test: The Provider Experience

Severity Variant rs10191329 has no Effect on Prognostic Factors, Serum GFAP Levels and Cognitive Impairment in Turkish Patients With Multiple Sclerosis